Article abstract


Nature Chemical Biology 4, 126 - 131 (2008)
Published online: 13 January 2008 | doi:10.1038/nchembio.64

Conformational cross-talk between alpha2A-adrenergic and mu-opioid receptors controls cell signaling

Jean-Pierre Vilardaga1,2, Viacheslav O Nikolaev3,4, Kristina Lorenz3, Sébastien Ferrandon1,2, Zhenjie Zhuang1,2 & Martin J Lohse3,4


Morphine, a powerful analgesic, and norepinephrine, the principal neurotransmitter of sympathetic nerves, exert major inhibitory effects on both peripheral and brain neurons by activating distinct cell-surface G protein–coupled receptors—the mu-opioid receptor (MOR) and alpha2A-adrenergic receptor (alpha2A-AR), respectively. These receptors, either singly or as a heterodimer, activate common signal transduction pathways mediated through the inhibitory G proteins (Gi and Go). Using fluorescence resonance energy transfer microscopy, we show that in the heterodimer, the MOR and alpha2A-AR communicate with each other through a cross-conformational switch that permits direct inhibition of one receptor by the other with subsecond kinetics. We discovered that morphine binding to the MOR triggers a conformational change in the norepinephrine-occupied alpha2A-AR that inhibits its signaling to Gi and the downstream MAP kinase cascade. These data highlight a new mechanism in signal transduction whereby a G protein–coupled receptor heterodimer mediates conformational changes that propagate from one receptor to the other and cause the second receptor's rapid inactivation.

Top
  1. Center of Systems Biology, Massachusetts General Hospital and Harvard Medical School, 185 Cambridge Street, CPZN 8-218, Boston, Massachusetts 02114, USA.
  2. Endocrine Unit, Massachusetts General Hospital and Harvard Medical School, 185 Cambridge Street, CPZN 8-218, Boston, Massachusetts 02114, USA.
  3. Rudolf-Virchow Center, DFG-Research Center for Experimental Biomedicine, University of Würzburg, Versbacher Strasse 9, 98078 Würzburg, Germany.
  4. Institute of Pharmacology and Toxicology, University of Würzburg, Versbacher Strasse 9, 98078 Würzburg, Germany.

Correspondence to: Jean-Pierre Vilardaga1,2 e-mail: vilardaga.jeanpierre@mgh.harvard.edu



MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

New eyes to see texture in ligand efficacy

Nature Methods News and Views (01 Mar 2005)

G-protein activation live

Nature Cell Biology News and Views (01 May 2001)

See all 5 matches for News And Views

Extra navigation

Subscribe to Nature Chemical Biology

Subscribe

Open Innovation Challenges

naturejobs

  • Faculty Positions

    • University of Texas Medical Branch
    • Galveston, TX United States
  • Data Manager

    • Philip Morris International (PMI)
    • Neuchatel Switzerland